ANNOUNCEMENT

Save $150 on MedCity CONVERGE Healthcare Innovation Summit July 9-10 in Philadelphia. Offer ends July 8..

Columbus, Pittsburgh angel groups among most active nationally in healthcare deals

July 23, 2012 1:11 pm by | 0 Comments

Two angel groups in flyover country have been keeping up with firms on the West Coast over the last 12 months, at least in terms of investing in healthcare startups.

The Halo Report included BlueTree Allied Angels and Ohio TechAngels in their list of most active companies in the health space.

Both groups participated in a recent funding round in Neuros Medical.

Advertisement

Central Texas Angel Network, Tech Coast Angels, Desert Angels, and Life Science Angels were the other firms placing the biggest bets on health companies.

The report also noted that 81 percent of deals took place outside California.

California companies are still winning the most money, though, with 25 percent of the total. Companies in the Southeast took in 18 percent.

Healthcare companies got a few more dollars than Internet companies at 32 percent of total dollars versus 30 percent.

The Halo Report analyzes investment activity by angels and angel groups, and highlights trends in round sizes, location and industry preferences. The data is collected via survey and aggregation of public data.

Download the entire report here.

Copyright 2013 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Veronica Combs

By Veronica Combs

I am the editor in chief at MedCityNews.com. I started writing and editing in the print world and joined a dotcom right before the 2000 crash. I was at TechRepublic/CNET/BNET for 7 years. Health was more interesting to me than the latest version of Windows, so I left for a startup tracking prescription drug news. A year later, MedTrackAlert was acquired by HealthCentral, so I shifted to audience research. The fun of daily news and interviewing smart people brought me to MedCity News in February 2012.
More posts by Author

0 comments

Stay Up To Date

Recent Comments

Research Center

Jobs Board

Next Story
Late-stage cystic fibrosis, muscular dystrophy drug raises $30 million
Close